Inability of NS1 protein from an H5N1 influenza virus to activate PI3K/Akt signaling pathway correlates to the enhanced virus replication upon PI3K inhibition

Veterinary Research

Volumn 43, Issue 1, 2012, Pages

  Li, Weizhong ^a,b   Wang, Gefei ^a   Zhang, Heng ^a   Shen, Yanqin ^a   Dai, Jianping ^a   Wu, Liqi ^a   Zhou, Jianxiang ^a   Jiang, Zhiwu ^a   Li, Kangsheng ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INS1 PROTEIN, INFLUENZA VIRUS; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ANIMAL DISEASE; ARTICLE; CELL LINE; DOG; GENETICS; HELA CELL LINE; HUMAN; INFLUENZA VIRUS A H5N1; MDCK CELL LINE; METABOLISM; MOLECULAR GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; DOGS; HELA CELLS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; MADIN DARBY CANINE KIDNEY CELLS; MOLECULAR SEQUENCE DATA; PHOSPHATIDYLINOSITOL 3-KINASE; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 84864486182     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1186/1297-9716-43-36     Document Type: Article

References (36)

1. A new player in a deadly game: influenza viruses and the PI3K/Akt signalling pathway. Ehrhardt C, Ludwig S, Cell Microbiol 2009 11 863 871 10.1111/j.1462-5822.2009.01309.x 19290913
2. Influenza virus and cell signaling pathways. Gaur P, Munjhal A, Lal SK, Med Sci Monit 2011 17 A148 154 21629204
3. Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. Ehrhardt C, Wolff T, Pleschka S, Planz O, Beermann W, Bode JG, Schmolke M, Ludwig S, J Virol 2007 81 3058 3067 10.1128/JVI.02082-06 17229704 (Pubitemid 46456615)
4. Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Hale BG, Jackson D, Chen YH, Lamb RA, Randall RE, Proc Natl Acad Sci U S A 2006 103 14194 14199 10.1073/pnas. 0606109103 16963558 (Pubitemid 44453002)
5. SH3 binding motif 1 in influenza A virus NS1 protein is essential for PI3K/Akt signaling pathway activation. Shin YK, Li Y, Liu Q, Anderson DH, Babiuk LA, Zhou Y, J Virol 2007 81 12730 12739 10.1128/JVI.01427-07 17881440 (Pubitemid 350156910)
6. Effect of the phosphatidylinositol 3-kinase/Akt pathway on influenza A virus propagation. Shin YK, Liu Q, Tikoo SK, Babiuk LA, Zhou Y, J Gen Virol 2007 88 942 950 10.1099/vir.0.82483-0 17325368 (Pubitemid 46359565)
7. Activation of phosphatidylinositol 3-kinase signaling by the nonstructural NS1 protein is not conserved among type A and B influenza viruses. Ehrhardt C, Wolff T, Ludwig S, J Virol 2007 81 12097 12100 10.1128/JVI.01216-07 17715214 (Pubitemid 47623843)
8. Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence. Ehrhardt C, Marjuki H, Wolff T, Nurnberg B, Planz O, Pleschka S, Ludwig S, Cell Microbiol 2006 8 1336 1348 10.1111/j.1462-5822.2006.00713.x 16882036
9. PI3K signalling during influenza A virus infections. Hale BG, Randall RE, Biochem Soc Trans 2007 35 186 187 10.1042/BST0350186 17371234 (Pubitemid 46596464)
10. Avian and 1918 Spanish influenza a virus NS1 proteins bind to Crk/CrkL Src homology 3 domains to activate host cell signaling. Heikkinen LS, Kazlauskas A, Melen K, Wagner R, Ziegler T, Julkunen I, Saksela K, J Biol Chem 2008 283 5719 5727 18165234
11. Characterization of the interaction of influenza virus NS1 with Akt. Matsuda M, Suizu F, Hirata N, Miyazaki T, Obuse C, Noguchi M, Biochem Biophys Res Commun 2010 395 312 317 10.1016/j.bbrc.2010.03.166 20362551
12. Influenza A viruses induce PI3-kinase activation by two interdependent mechanisms late in the infection cycle. Ehrhardt C, Hrincius ER, Anhlan D, Ludwig S, Cell Commun and Sign 2009 7 Suppl 1 43 10.1186/1478-811X-7-S1-A43
13. Phosphatidylinositol-3-kinase (PI3K) is activated by influenza virus vRNA via the pathogen pattern receptor Rig-I to promote efficient type I interferon production. Hrincius ER, Dierkes R, Anhlan D, Wixler V, Ludwig S, Ehrhardt C, Cell Microbiol 2011 13 1907 1919 10.1111/j.1462-5822.2011.01680.x 21899695
14. Binding of influenza A virus NS1 protein to the inter-SH2 domain of p85 suggests a novel mechanism for phosphoinositide 3-kinase activation. Hale BG, Batty IH, Downes CP, Randall RE, J Biol Chem 2008 283 1372 1380 18029356
15. Structural insights into phosphoinositide 3-kinase activation by the influenza A virus NS1 protein. Hale BG, Kerry PS, Jackson D, Precious BL, Gray A, Killip MJ, Randall RE, Russell RJ, Proc Natl Acad Sci U S A 2010 107 1954 1959 10.1073/pnas.0910715107 20133840
16. Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K. Shin YK, Liu Q, Tikoo SK, Babiuk LA, Zhou Y, J Gen Virol 2007 88 13 18 10.1099/vir.0.82419-0 17170431 (Pubitemid 46085109)
17. Mechanism of influenza A virus NS1 protein interaction with the p85beta, but not the p85alpha, subunit of phosphatidylinositol 3-kinase (PI3K) and up-regulation of PI3K activity. Li Y, Anderson DH, Liu Q, Zhou Y, J Biol Chem 2008 283 23397 23409 10.1074/jbc.M802737200 18534979
18. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM, Mol Cell 1998 1 991 1000 10.1016/S1097-2765(00) 80099-4 9651582 (Pubitemid 128379260)
19. Multiple anti-interferon actions of the influenza A virus NS1 protein. Kochs G, Garcia-Sastre A, Martinez-Sobrido L, J Virol 2007 81 7011 7021 10.1128/JVI.02581-06 17442719 (Pubitemid 46986637)
20. The H5N1 influenza virus NS genes selected after 1998 enhance virus replication in mammalian cells. Twu KY, Kuo RL, Marklund J, Krug RM, J Virol 2007 81 8112 8121 10.1128/JVI.00006-07 17522219 (Pubitemid 47101497)
21. Effects of NS1 variants of H5N1 influenza virus on interferon induction, TNFalpha response and p53 activity. Li W, Wang G, Zhang H, Xin G, Zhang D, Zeng J, Chen X, Xu Y, Cui Y, Li K, Cell Mol Immunol 2010 7 235 242 10.1038/cmi.2010.6 20228833
22. Mechanism of activation of protein kinase B by insulin and IGF-1. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, Hemmings BA, EMBO J 1996 15 6541 6551 8978681 (Pubitemid 26413787)
23. The phosphoinositide 3-kinase pathway. Cantley LC, Science 2002 296 1655 1657 10.1126/science.296.5573.1655 12040186 (Pubitemid 34579158)
24. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Li KS, Guan Y, Wang J, Smith GJ, Xu KM, Duan L, Rahardjo AP, Puthavathana P, Buranathai C, Nguyen TD, Estoepangestie AT, Chaisingh A, Auewarakul P, Long HT, Hanh NT, Webby RJ, Poon LL, Chen H, Shortridge KF, Yuen KY, Webster RG, Peiris JS, Nature 2004 430 209 213 10.1038/nature02746 15241415 (Pubitemid 38902429)
25. H5N1 influenza: a protean pandemic threat. Guan Y, Poon LL, Cheung CY, Ellis TM, Lim W, Lipatov AS, Chan KH, Sturm-Ramirez KM, Cheung CL, Leung YH, Yuen KY, Webster RG, Peiris JS, Proc Natl Acad Sci U S A 2004 101 8156 8161 10.1073/pnas.0402443101 15148370 (Pubitemid 38698070)
26. Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events. Geiss GK, An MC, Bumgarner RE, Hammersmark E, Cunningham D, Katze MG, J Virol 2001 75 4321 4331 10.1128/JVI.75.9.4321-4331.2001 11287581 (Pubitemid 32410144)
27. Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit. Miled N, Yan Y, Hon WC, Perisic O, Zvelebil M, Inbar Y, Schneidman-Duhovny D, Wolfson HJ, Backer JM, Williams RL, Science 2007 317 239 242 10.1126/science.1135394 17626883 (Pubitemid 47076198)
28. Loss of function of the influenza A virus NS1 protein promotes apoptosis but this is not due to a failure to activate phosphatidylinositol 3-kinase (PI3K). Jackson D, Killip MJ, Galloway CS, Russell RJ, Randall RE, Virology 2010 396 94 105 10.1016/j.virol.2009.10.004 19880155
29. Control of apoptosis in influenza virus-infected cells by up-regulation of Akt and p53 signaling. Zhirnov OP, Klenk HD, Apoptosis 2007 12 1419 1432 10.1007/s10495-007-0071-y 17468837 (Pubitemid 46988278)
30. Regulation of hepatitis B virus replication by the phosphatidylinositol 3-kinase-akt signal transduction pathway. Guo H, Zhou T, Jiang D, Cuconati A, Xiao GH, Block TM, Guo JT, J Virol 2007 81 10072 10080 10.1128/JVI.00541-07 17609269 (Pubitemid 350067711)
31. Activation of the N-Ras-PI3K-Akt-mTOR pathway by hepatitis C virus: control of cell survival and viral replication. Mannova P, Beretta L, J Virol 2005 79 8742 8749 10.1128/JVI.79.14.8742-8749.2005 15994768 (Pubitemid 40934785)
32. Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Sarkar SN, Peters KL, Elco CP, Sakamoto S, Pal S, Sen GC, Nat Struct Mol Biol 2004 11 1060 1067 10.1038/nsmb847 15502848 (Pubitemid 39453334)
33. Signalling pathways mediating type I interferon gene expression. Edwards MR, Slater L, Johnston SL, Microbes Infect 2007 9 1245 1251 10.1016/j.micinf. 2007.06.008 17904888 (Pubitemid 47554534)
34. Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3K-dependent NF-kappaB activation. Chang TH, Liao CL, Lin YL, Microbes Infect 2006 8 157 171 10.1016/j.micinf.2005.06.014 16182584 (Pubitemid 43139304)
35. PI3K is critical for the nuclear translocation of IRF-7 and type I IFN production by human plasmacytoid predendritic cells in response to TLR activation. Guiducci C, Ghirelli C, Marloie-Provost MA, Matray T, Coffman RL, Liu YJ, Barrat FJ, Soumelis V, J Exp Med 2008 205 315 322 10.1084/jem.20070763 18227218 (Pubitemid 351281597)
36. Role of the Akt pathway in mRNA translation of interferon-stimulated genes. Kaur S, Sassano A, Dolniak B, Joshi S, Majchrzak-Kita B, Baker DP, Hay N, Fish EN, Platanias LC, Proc Natl Acad Sci U S A 2008 105 4808 4813 10.1073/pnas.0710907105 18339807 (Pubitemid 351753828)